2005
Discrimination and calibration of mortality risk prediction models in interventional cardiology
Matheny M, Ohno-Machado L, Resnic F. Discrimination and calibration of mortality risk prediction models in interventional cardiology. Journal Of Biomedical Informatics 2005, 38: 367-375. PMID: 16198996, DOI: 10.1016/j.jbi.2005.02.007.Peer-Reviewed Original ResearchMeSH KeywordsAngioplasty, Balloon, CoronaryCalibrationCardiologyComorbidityDecision Support Systems, ClinicalDiagnosis, Computer-AssistedDiscriminant AnalysisExpert SystemsHumansIncidenceOutcome Assessment, Health CarePostoperative ComplicationsPrognosisRetrospective StudiesRisk AssessmentRisk FactorsROC CurveSurvival AnalysisSurvival RateUnited StatesConceptsLocal risk modelAcute myocardial infarctionHosmer-Lemeshow goodnessRisk prediction modelRisk factorsCardiology-National Cardiovascular Data RegistryConsecutive percutaneous coronary interventionsMortality risk prediction modelPercutaneous coronary interventionMultivariate risk factorsCertain risk factorsROC curveAccurate risk predictionIndividual casesGood discriminationCardiogenic shockHospital mortalityCoronary interventionUnstable anginaArtery interventionPatient populationMyocardial infarctionRisk modelElective proceduresWomen's Hospital
2003
No-reflow is an independent predictor of death and myocardial infarction after percutaneous coronary intervention
Resnic F, Wainstein M, Lee M, Behrendt D, Wainstein R, Ohno-Machado L, Kirshenbaum J, Rogers C, Popma J, Piana R. No-reflow is an independent predictor of death and myocardial infarction after percutaneous coronary intervention. American Heart Journal 2003, 145: 42-46. PMID: 12514653, DOI: 10.1067/mhj.2003.36.Peer-Reviewed Original ResearchConceptsPercutaneous coronary interventionPostprocedural myocardial infarctionStrong independent predictorMyocardial infarctionIndependent predictorsSodium nitroprussideInhospital outcomesCoronary interventionClinical outcomesSaphenous vein graft interventionIntracoronary vasodilator therapyVein graft interventionAdministration of verapamilAcute myocardial infarctionRate of deathInhospital mortalityVasodilator therapyCardiogenic shockBaseline demographicsGraft interventionUnstable anginaAdverse eventsConsecutive patientsIntracoronary verapamilInfarction